Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI

Delayed Quote. Delayed  - 05/27 09:59:59 pm
7.43 USD   -0.13%
05/16 DEADLINE UPCOMI : SPPI) Investor Lawsuit
05/06 SPECTRUM PHARMA : Highlights an Oral Presentation on Apaziquone at t..
05/05 SPECTRUM PHARMA : Pharma reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
7.3(c) 7.37(c) 7.53(c) 7.44(c) 7.43(c) Last
591 219 942 448 814 653 825 647 639 443 Volume
+0.41% +0.96% +2.17% -1.20% -0.13% Change
More quotes
Financials ($)
Sales 2016 136 M
EBIT 2016 -56,1 M
Net income 2016 -80,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 114 M
EBIT 2017 -58,9 M
Net income 2017 -78,0 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 3,78x
Capi. / Sales 2017 4,53x
Capitalization 514 M
More Financials
Company
Spectrum Pharmaceuticals, Inc develops and manufactures pharmaceutical products.The firm acquires, develops, and commercializes a pipeline of clinical and commercial products under the FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, and BELEODAQ brands.The company was founded in December 1987 and is... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
05/25 SPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K)
05/16 DEADLINE UPCOMING IN $7 MILLION SETT : SPPI) Investor Lawsuit
05/06 SPECTRUM PHARMACEUTICALS : Highlights an Oral Presentation on Apaziquone at the ..
05/05 SPECTRUM PHARMACEUTICALS : Pharma reports 1Q loss
05/05 SPECTRUM PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
05/05 SPECTRUM PHARMACEUTICALS : Reports First Quarter 2016 Financial Results and Pipe..
05/05 SPECTRUM PHARMACEUTICALS : Reports First Quarter 2016 Financial Results and Pipe..
05/03 SPECTRUM PHARMACEUTICALS : to Present Corporate Update at the Bank of America Me..
04/28 SPECTRUM PHARMACEUTICALS : Announces First Quarter 2016 Financial Results Teleco..
04/21 SPECTRUM PHARMACEUTICALS : Patent Issued for Treatment of Primary and Metastatic..
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/25 Spectrum Pharma settles Folotyn patent squabble with Teva
05/05 Spectrum Pharmaceuticals' (SPPI) CEO Rajesh Shrotriya on Q1 2016 Results - Ea..
05/05 Spectrum Pharmaceuticals beats by $0.18, beats on revenue
05/04 Notable earnings after Thursday?s close
04/20 FDA grants seven-year Orphan Drug exclusivity for Spectrum Pharma's Evomela; ..
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends SPECTRUM PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions